Drug intelligence / Profile preview

PlatiSoon

Development stage: Unknown
Lead developer: Arbro Pharmaceuticals
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

PlatiSoon (also written as PLATI SOON) is a marketed herbal and Ayurvedic capsule formulation developed by Arbro Pharmaceuticals. It is composed of a combination of Carica Papaya (papaya leaf), Giloy (Tinospora cordifolia), Tulsi (Ocimum sanctum/holy basil), and Self Nano Emulsifying Curcumin (SNEC). PlatiSoon is indicated as a natural platelet enhancer to support platelet count restoration and immune modulation in patients suffering from dengue fever, viral infections, malaria, chemotherapy-induced thrombocytopenia, and low immunity.

Brand names: PLATI SOONPlatiSoon
Other names: Carica Papaya + Giloy + Tulsi + CurcuminCarica Papaya + Tinospora cordifolia + Ocimum sanctum + Curcumin

Beyond the preview

Go deeper on PlatiSoon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PlatiSoon.